南京科佰生物科技有限公司官方网站欢迎您的光临!
免费咨询热线: 4008-750-250
科研细胞
药靶细胞
标准品
NGS靶向捕获探针
NCI-H727(人肺支气管良性肿瘤)
CBP60182 | |
I. General information | |
Synonyms: | NCI-H727 |
Background: | This line was derived by A.F. Gazdar, H.K. Oie, J.D. Minna and associates from tissue taken prior to therapy. |
Species: | Homo sapiens, human |
Tissue: | lung, bronchus |
Disease: | carcinoid |
Gender: | female,65 years,Caucasian |
Morphology: | epithelial |
Growth Mode: | adherent |
DNA Profile: | Amelogenin: X CSF1PO: 11,12 D13S317: 11 D16S539: 11,13 D5S818: 11,12 D7S820: 8,10 THO1: 8 TPOX: 8 vWA: 14,15 Cobioer’s Cell Line Authentication Service |
Culture Medium: | RPMI-1640+20%FBS We strongly suggest to purchase the complete medium from Cobioer. |
Cryopreservation medium: | 90%FBS+10%DMSO |
Receptor Expression: | epidermal growth factor (EGF) |
Genes Expressed: | neuromedin B (NMB) |
Cellular Products: | neuromedin B (NMB) |
Comments: | This is the best differentiated of the available bronchial carcinoid lines.The cells express easily detectable levels of p53 mRNA compared to levels found in normal lung.The cells are able to synthesize the peptide NMB (at 0.1 pmol/mg protein), but not the gastrin releasing peptide (GRP). The cell line secretes a parathyroid hormone-like protein which is calcium stimulated through a protein kinase C pathway.Growth of NCI-H727 cells is inhibited by epidermal growth factor (EGF) receptor monoclonal antibodies. For more information, please contact Cobioer (4008-750-250). |

扫一扫,关注我们公众号
Copyright ©2021 www.cobioer.com All Rights Reserved. 南京科佰生物科技有限公司版权所有 苏ICP备13038923号